Topics
Glioblastoma | Treatment | Immunotherapy | Ipilimumab
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Ipilimumab
Neuro-Oncology Clinical Research Program; Camphausen K.
Phase
II Trial Evaluating the Association of Peripheral Blood
Immunologic Response to Therapeutic Response After Adjuvant
Treatment with Immune Checkpoint Inhibition (ICI) in Patients with
Newly Diagnosed Glioblastoma or Gliosarcoma.
medRxiv
[Preprint]. 2025 Dec 30:2025.12.23.25342908. doi:
10.64898/2025.12.23.25342908. PMID:
41607658. Trial
registration ID: NCT04817254. ˍ